GLDC p.Pro163=
c.489A>G · rs770044310 · VCV702890
Computational evidence
| Protein change | ||
| Missense predictors do not apply to this variant type; conservation carries the signal. | ||
| Splicing | ||
| SpliceAI | — | not assessed · no allele here is in the release |
|---|---|---|
| Constraint at this position | ||
| Conservation | phyloP -15 | GERP -3.1 |
| Overall | ||
| CADD | 0.164 | PHRED · no single calibrated threshold — expert panels disagree |
Population frequency
| Ancestry group | Frequency | 1 in |
|---|---|---|
| East Asiangrpmax | 0.0535% | 1,871 |
| Remaining individualsnot grpmax-eligible | 0.0064% | 15,621 |
| African / African-American | 0.004% | 24,981 |
| European (non-Finnish) | 0.000254% | 393,297 |
Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.
Variant & gene context
- Gene
- GLDC
- Protein
- p.Pro163=
- Coding
- c.489A>G
- MANE Select
- NM_000170
- dbSNP
- rs770044310
- Type
- single nucleotide variant
- Location
- chr9:6610338 (GRCh38)
- Gene constraint
- LOEUF 1.09 · pLI <0.01 (gnomAD)
- Structure
- AlphaFold pLDDT 94.50 · 3 PDB
Disease context
glycine encephalopathy — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatmentsFor Glycine encephalopathy (Orphanet):
- Inheritance
- Autosomal recessive
- Onset
- Infancy, Neonatal
- Prevalence
- 1-9 / 1 000 000 (Europe)
Similar variants
- GLDC p.Pro163Leu Uncertain significance ★ ⚠ same residue
- GLDC c.1401+1G>A Pathogenic/Likely pathogenic ★★ same condition
- GLDC c.1580+2T>G Pathogenic ★★ same condition
- GLDC c.1851-1G>A Pathogenic ★★ same condition
- GLDC c.2053-2A>G Likely pathogenic ★★ same condition
- GLDC c.2203-2A>G Pathogenic/Likely pathogenic ★★ same condition
- GLDC c.2315+2T>A Pathogenic/Likely pathogenic ★★ same condition
- GLDC c.2315+2T>G Pathogenic/Likely pathogenic ★★ same condition
Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →
Cite Sugi Variant
Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gldc-p-pro163 (accessed [today's date]).
Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown